{
	"type": "rich",
	"version": "1.0",
	"provider_name": "Action Network",
	"provider_url": "https://actionnetwork.org",
	
	"html": "<link href='https://actionnetwork.org/css/style-embed-v3.css' rel='stylesheet' type='text/css' /><script src='https://actionnetwork.org/widgets/v6/letter/urge-congress-to-reform-340b?format=js&source=widget'></script><div id='can-letter-area-urge-congress-to-reform-340b' style='width: 100%'><!-- this div is the target for our HTML insertion --></div>",
	"author_name": "Rx in Reach",
	"author_url": "https://actionnetwork.org/groups/rx-in-reach",
	"title": "TELL GEORGIA LEGISLATORS TO OPPOSE HB 139",
	"thumbnail_url": "https://can2-prod.s3.amazonaws.com/letters/photos/000/377/754/normal/Rx_in_Reach_340B_Landing_Page.png",
	"description": "Over 6 million Georgians are living with at least one chronic illness and reliant on consistent and reliable access to the treatments prescribed by their health care provider to manage symptoms, control their illnesses, and lead healthier lives. The 340B Drug Pricing Program, otherwise known as 340B, was created by Congress just over 30 years ago to help low-income and uninsured patients across the country access discounted medications. While well intended, a lack of federal oversight has allowed 340B to evolve into a growing profit center for many hospitals and for profit-corporations. Much of this growth is due, in part, to 340B hospitals’ ability to also contract with an unlimited number of pharmacies, many of which are owned by the nation’s largest pharmacy benefit managers (PBMs) and insurers. As a result, PBMs and 340B contract pharmacies can also rake in massive profits from discounted 340B medicines. Join me and send a letter to your state lawmakers urging oppose House Bill 139 (HB139), legislation that will facilitate further abuse of the 340B program and allow hospitals and PBMs to continue profiting at the expense of vulnerable patients. Stand with patients today!",
	"url": "https://actionnetwork.org/letters/urge-congress-to-reform-340b"
}